| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/23/2005 | CN1597662A A kind of aromatic acid amide compound its preparation method and use |
| 03/23/2005 | CN1193746C Substituted nitrobenzene derimative for medicine and other use |
| 03/23/2005 | CN1193743C Multilayer pharmaceutical product for release in the colon |
| 03/22/2005 | US6869969 Isoxazole estrogen receptor agonist and antagonist |
| 03/22/2005 | US6869941 Combination of drospirenone and an estrogen sulphamate for HRT |
| 03/22/2005 | US6869932 Immobilizated growth hormone releasing factor |
| 03/17/2005 | WO2005023771A1 Chemokine receptor antagonist and medical use thereof |
| 03/17/2005 | WO2005023230A1 Composition containing nanoparticles containing water-soluble basic drug encapsulated therein |
| 03/17/2005 | WO2004099395A3 A method for the generation of neural progenitor cells |
| 03/17/2005 | WO2004083243A8 Amylin aggregation inhibitors and use thereof. |
| 03/17/2005 | WO2003045918A8 Piperidine-based mch antagonists for treatment of obesity and cns disorders |
| 03/17/2005 | WO2003037887A8 Therapeutic isoquinoline compounds |
| 03/17/2005 | WO2002050028A8 Substituted benzoindoles as spla2 inhibitors |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059723 Indole or carbazole oximes such as 1-(4-Hydroxyphenyl)-2-methyl-1H-indole-3-carbaldehyde oxime; estrogen receptor modulators for treating bone disorders, nervous system disorders, proliferative disorders including cancer, skin disorders, urogenital disorders and cardiovascular disorders |
| 03/17/2005 | US20050059714 2-Cyclopropyl-4-(5-fluoro-2-methoxyphenyl)-4-methyl-1-(1H-pyrrolo[2,3-c]pyridin-2-yl)pentan-2-ol; treating diseases of inflammatory, allergic, or proliferative condition; type II diabetes, obesity, cardiovascular diseases, hypertension, arteriosclerosis, neurological diseases, adrenal and pituitary tumor |
| 03/17/2005 | US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/17/2005 | US20050059691 Novel polymorphic form of 17-beta-(N-ter. butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it |
| 03/17/2005 | US20050059686 Pyrrolopyrimidines as phosphodiesterase vII inhibitors |
| 03/17/2005 | US20050059616 administering flavonoids and optionally vitamin E or excipients for the prophylaxis of bone or cardiovascular disorders, headaches, hypertension, cancers, leukemia, arteriosclerosis, Alzheimer's disease, inflammatory diseases, rheumatic diseases, acne, alopecia or psoriasis |
| 03/17/2005 | US20050059577 Glycosylphosphatidylinositol containing polypeptides |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | CA2537802A1 Composition containing nanoparticles containing water-soluble basic drug encapsulated therein |
| 03/16/2005 | EP1514942A1 Method of searching substane having antidiabetic activity |
| 03/16/2005 | EP1513861A2 New etonogestrel esters |
| 03/16/2005 | EP1513839A1 3-substituted quinuclidines and their use |
| 03/16/2005 | EP1513837A1 Thiazole derivatives as phosphodiesterase iv inhibitors |
| 03/16/2005 | EP1513810A1 4-(aryl or heteroaryl) -2-butylamine derivatives and their use as glucocorticoid ligans |
| 03/16/2005 | EP1513808A2 Fluorinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 03/16/2005 | EP1513796A2 Phenyloxyalkanoic acid derivatives as hppar activators |
| 03/16/2005 | EP1513588A2 Use of new etonogestrel esters |
| 03/16/2005 | EP1513545A2 Methods and means to promote gut absorption |
| 03/16/2005 | EP1513493A2 Analgesics |
| 03/16/2005 | EP1513482A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna) |
| 03/16/2005 | EP1399436B1 Oxytocin agonists |
| 03/16/2005 | EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 03/16/2005 | EP1355903B1 Pyrazole derivatives against tgf overexpression |
| 03/16/2005 | EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/16/2005 | EP1146873B1 Anti-androgens and methods for treating disease |
| 03/16/2005 | CN1596305A Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 03/16/2005 | CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 03/16/2005 | CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues |
| 03/16/2005 | CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer |
| 03/16/2005 | CN1596105A Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate |
| 03/16/2005 | CN1594358A Method for reducing or inhibition of proliferation of oncogenic cells and compound used in it (variants) |
| 03/16/2005 | CN1593561A Selective moderator composition of estrogen receptor and preparation process thereof |
| 03/16/2005 | CN1193026C Z-pyrazoline-5-ones |
| 03/16/2005 | CN1193025C Novel 1, 3-dihydro-2H-indol-2-one derivatives, their preparing method and pharmceutical composition containing the same |
| 03/16/2005 | CN1192767C Capsule and binding agent for pharmaceutical formulations with improved storage stability |
| 03/15/2005 | US6867202 Treatment of insulin resistance |
| 03/15/2005 | US6867184 Methods of treating diabetic cardiomyopathy using glycogen phosphorylase inhibitors |
| 03/15/2005 | US6867003 Grb14, Grb14 fusion proteins, and screening methods |
| 03/15/2005 | CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
| 03/10/2005 | WO2005021555A1 Bicyclic piperazine compound and use thereof |
| 03/10/2005 | WO2005021524A1 Process for the preparation of amorphous form of repaglinide |
| 03/10/2005 | WO2005020979A1 A process for the preparation of pharmaceutical compositions of nateglinide |
| 03/10/2005 | WO2005020967A1 Electric drug transport preparation |
| 03/10/2005 | WO2005000795A3 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 03/10/2005 | WO2003104260A3 Pharmaceutical formulation |
| 03/10/2005 | US20050054729 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; treating of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 03/10/2005 | US20050054711 with a substituted benzene ring; agonists of the progesterone receptorinducing contraception treating progesterone-related carcinomas and adenocarcinomas |
| 03/10/2005 | US20050054706 N-substituted pyrroles, pyrazoles, imidazoles, triazoles and tetrazoles used for treating and preventing cancer, inflammation, autoimmune diseases, respiratory system disorders, septic shock, pain, preterm labor, as dietetics and sexual disorders, and disorders associated with MAP kinases |
| 03/10/2005 | US20050054700 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 03/10/2005 | US20050054685 Pharmaceutical composition |
| 03/10/2005 | US20050054674 Activator of peroxisome proliferator-activated receptor |
| 03/10/2005 | US20050054632 Naphthyl compounds, intermediates, compositions, and methods of use |
| 03/10/2005 | US20050054623 Transdermal supplying testosterone gel |
| 03/10/2005 | US20050054622 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 03/10/2005 | US20050054595 Genetic engineering; gene expression of target agent |
| 03/10/2005 | US20050054584 Reducing weight and damage cuased by diabetes; antidiabetic agents |
| 03/10/2005 | US20050054581 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor |
| 03/10/2005 | US20050054580 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 03/10/2005 | US20050054102 Culturing preferential stem cells and generating pancreatic beta cell tissues via transfection for use in treatment of diabetes, hyperglycemia, and/or impaired glucose tolerance; tissue engineering; regenerative medicine |
| 03/09/2005 | EP1512739A1 Chrondrocyte therapeutic delivery system |
| 03/09/2005 | EP1512403A1 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 03/09/2005 | EP1511763A2 Intracellular delivery of biological effectors |
| 03/09/2005 | EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 03/09/2005 | EP1511742A1 Kinase inhibitors |
| 03/09/2005 | EP1511737A1 Aryloximes |
| 03/09/2005 | EP1511736A1 Therapeutic molecules and methods-1 |
| 03/09/2005 | EP1511725A1 24-SULFOXIMINE VITAMIN D sb 3 /sb COMPOUNDS |
| 03/09/2005 | EP1511716A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/09/2005 | EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease |
| 03/09/2005 | EP1511502A2 Probiotic therapies using lactobacillus reuteri |
| 03/09/2005 | EP1511497A1 Treatment of post-menopausal complaints in breast cancer patients which comprises tibolone and a serm |
| 03/09/2005 | EP1511495A1 Progestagenic dosage units |
| 03/09/2005 | EP1511484A1 Combination of a dpp iv inhibitor and a cardiovascular compound |
| 03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
| 03/09/2005 | EP1126849B1 Heterocyclic potassium channel inhibitors |
| 03/09/2005 | EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 03/09/2005 | CN1592739A Novel piperidine based MCH antagonists for treatment of obesity and CNS disorders |
| 03/09/2005 | CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination |
| 03/09/2005 | CN1592630A Injection solution comprising an LHRH antagonist |
| 03/09/2005 | CN1592616A GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 03/09/2005 | CN1589778A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589777A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1589776A Microencapsulated saccharomyces and its application |
| 03/09/2005 | CN1191843C Active full-component wheat spear extract and its microcapsule and preparing process |